These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11121838)

  • 41. Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review.
    Derry F; Hultling C; Seftel AD; Sipski ML
    Urology; 2002 Sep; 60(2 Suppl 2):49-57. PubMed ID: 12414333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sildenafil: a milestone in the treatment of impotence.
    Nachtsheim D
    West J Med; 1998 Aug; 169(2):112-3. PubMed ID: 9735695
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer.
    Kedia S; Zippe CD; Agarwal A; Nelson DR; Lakin MM
    Urology; 1999 Aug; 54(2):308-12. PubMed ID: 10443730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of erection questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction.
    Lowy M; Collins S; Bloch M; Gillman M; Lording D; Sutherland P; Wang H; Stecher V
    J Sex Med; 2007 Jan; 4(1):83-92. PubMed ID: 17233777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
    Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
    J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sildenafil (Viagra). Hormonal properties, indications and legal problems].
    Ullrich T; Haen E
    Med Monatsschr Pharm; 1999 Aug; 22(8):233-45. PubMed ID: 10481434
    [No Abstract]   [Full Text] [Related]  

  • 50. Topical and oral agents for erectile dysfunction.
    Lue TF
    J Formos Med Assoc; 1999 Apr; 98(4):233-41. PubMed ID: 10389366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phosphodiesterase 5--the enzyme inhibited by sildenafil (Viagra)].
    Sandberg M; Natarajan V
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):945-9. PubMed ID: 10210955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sildenafil use in patients with olanzapine-induced erectile dysfunction.
    Atmaca M; Kuloglu M; Tezcan E
    Int J Impot Res; 2002 Dec; 14(6):547-9. PubMed ID: 12494295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is it safe for cardiological patients to take sildenafil (viagra) to correct erectile dysfunction? (lectures)].
    Metelitsa VI
    Ter Arkh; 2000; 72(6):67-9. PubMed ID: 10900657
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sildenafil: efficacy and safety in daily clinical experience.
    Palumbo F; Bettocchi C; Selvaggi FP; Pryor JP; Ralph DJ
    Eur Urol; 2001 Aug; 40(2):176-80. PubMed ID: 11528195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in ED therapy in the Viagra era.
    Krane RJ
    World J Urol; 2001 Feb; 19(1):23-4. PubMed ID: 11289566
    [No Abstract]   [Full Text] [Related]  

  • 60. Recent advances in the treatment of erectile dysfunction in patients with diabetes mellitus.
    Koppiker N; Boolell M; Price D
    Endocr Pract; 2003; 9(1):52-63. PubMed ID: 12917094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.